Treatment of severe COVID-19: an evolving paradigmArticle Published on 2022-12-012023-07-10 Journal: Expert opinion on pharmacotherapy [Category] [DOI] 10.1080/14656566.2022.2140041 PMC 바로가기
Recent clinical findings on the role of kinase inhibitors in COVID-19 managementCOVID-19 관리에서 키나제 억제제의 역할에 대한 최근 임상 결과Review Published on 2022-10-012022-09-11 Journal: Life sciences [Category] [DOI] 10.1016/j.lfs.2022.120809 PMC 바로가기 [Article Type] Review
Rheumatoid arthritis patients treated with Janus kinase inhibitors show reduced humoral immune responses following BNT162b2 vaccinationJanus kinase inhibitor로 치료받은 류마티스 관절염 환자, BNT162b2 백신 접종 후 체액성 면역 반응 감소Article Published on 2022-08-032022-09-12 Journal: Rheumatology (Oxford, England) [Category] [DOI] 10.1093/rheumatology/keab879 PMC 바로가기 [Article Type] Article
Single-cell RNA sequencing to decipher the immunogenicity of ChAdOx1 nCoV-19/AZD1222 and mRNA-1273 vaccines in patients with autoimmune rheumatic diseases자가면역 류마티스 질환 환자에서 ChAdOx1 nCoV-19/AZD1222 및 mRNA-1273 백신의 면역원성을 해독하기 위한 단일 세포 RNA 시퀀싱Article Published on 2022-08-012022-09-12 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.920865 PMC 바로가기 [Article Type] Article
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysisCOVID-19로 병원에 입원한 환자의 바리시티닙(RECOVERY): 무작위, 통제, 공개 라벨, 플랫폼 시험 및 업데이트된 메타 분석Meta-Analysis Published on 2022-07-302022-09-11 Journal: Lancet (London, England) [Category] [DOI] 10.1016/S0140-6736(22)01109-6 PMC 바로가기 [Article Type] Meta-Analysis
Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trialsResearch article Published on 2022-06-032022-10-05 Journal: EClinicalMedicine [Category] [DOI] 10.1016/j.eclinm.2022.101489 [Article Type] Research article
Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytesResearch article Published on 2022-05-252022-10-05 Journal: Cell Reports [Category] [DOI] 10.1016/j.celrep.2022.110945 [Article Type] Research article
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trialsCOVID-19로 입원한 환자를 위한 Janus kinase inhibitors: 무작위 대조 시험의 메타 분석Meta-Analysis Published on 2022-05-012022-09-11 Journal: Expert review of anti-infective therapy [Category] [DOI] 10.1080/14787210.2022.2004120 PMC 바로가기 [Article Type] Meta-Analysis
Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trialResearch article Published on 2022-05-012022-10-05 Journal: The Lancet Rheumatology [Category] [DOI] 10.1016/S2665-9913(22)00044-3 [Article Type] Research article
JAK inhibitors and COVID-19JAK 억제제 및 COVID-19Review Published on 2022-04-012022-09-11 Journal: Journal for immunotherapy of cancer [Category] [DOI] 10.1136/jitc-2021-002838 PMC 바로가기 [Article Type] Review